Victory Capital Management Inc Clearside Biomedical, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$1.55 - $2.41 $9,761 - $15,178	-6,298 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$1.32 - $3.77 $423 - $1,210	321 Added 5.37%	6,298 $11,000
Q4 2019 Feb 04, 2020	BUY	$0.62 - $3.4 $182 - $999	294 Added 5.17%	5,977 $23,000
Q3 2019 Nov 12, 2019	BUY	$0.59 - $1.32 $3,352 - $7,501	5,683 New	5,683 $4,000

11.6M

24K

12.1K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $54.2M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.